# Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

> **NCT00120783** · PHASE2 · TERMINATED · sponsor: **French National Agency for Research on AIDS and Viral Hepatitis** · enrollment: 40 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Indinavir
- **DRUG:** Lamivudine
- **DRUG:** Ritonavir

## Key facts

- **NCT ID:** NCT00120783
- **Lead sponsor:** French National Agency for Research on AIDS and Viral Hepatitis
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-02
- **Primary completion:** —
- **Final completion:** 2003-08
- **Target enrollment:** 40 (—)
- **Last updated:** 2007-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00120783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00120783, "Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance". Retrieved via MORVS 2026-10-31 from https://api.morvs.ai/clinical/NCT00120783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*